Based on recent data, Inari Medical, Inc. (NARI) shows an Average True Range (ATR) of 0.7 and an Enterprise Value of 2.21B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into NARI's underlying financial health and market activity.
| ATR | 0.7 |
| Enterprise Value | 2.21B |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Inari Medical, Inc. (NARI) technical indicators as of February 6, 2026: the SMA 20 is 0.28%, SMA 50 at 16.76%, and SMA 200 at 52.1%. The RSI 14 value is 79.6, suggesting its current momentum. These technical analysis signals help assess NARI's price trends and potential future movements.
| SMA 20 | 0.28% |
| SMA 50 | 16.76% |
| SMA 200 | 52.1% |
| RSI 14 | 79.6 |
Inari Medical, Inc. (NARI) stock performance overview as of February 6, 2026: The 52-week high is $79.99 (currently -0.02% below), and the 52-week low is $79.76 (currently 117.72% above). Over the past year, NARI's performance is N/A, compared to the S&P 500's 8.96% change.
| 52-Week High | 79.99 |
| 52-Week High Chg | -0.02% |
| 52-Week Low | 79.76 |
| 52-Week Low Chg | +117.72% |
| S&P 500 52-Week Chg | 8.96% |
According to market data, Inari Medical, Inc. (NARI) stock's recent performance metrics show that over the last month, NARI is 0.72%, with a Year-to-Date (YTD) performance of 56.65%. Over the past year, the stock has seen a N/A change. These figures summarize NARI's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 79.99 | 79.99 | 79.99 | 79.99 | 79.99 | N/A |
| Low | 79.85 | 79.76 | 79.76 | 79.76 | 79.76 | N/A |
| Performance | +0.14% | +0.72% | +57.51% | +61.07% | - | +56.65% |
According to current financial data, NARI stock's P/E (TTM) ratio is -2775.03, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for NARI, including P/S (9.49), P/B (9.77), and P/FCF (157.55), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | NARI | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2775.03 | -1.23 | -26.18 | 32.59 |
| P/S (TTM) | 9.49 | 3.71 | 14.12 | 5.98 |
| P/B (TTM) | 9.77 | 0.22 | -0.58 | 5.45 |
| P/FCF (TTM) | 157.55 | -6.66 | -751.52 | 31.94 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep